LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

Home・Aandelen Lijst・Vivani Medical

Vivani Medical

Gesloten

1.08 -2.7

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.08

Max

1.1

Belangrijke statistieken
By Trading Economics
Inkomsten	614K -6.5M
Werknemers	37

Dividenden
By Dow Jones
Volgende Winsten	30 mrt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-25M 79M
Vorige openingsprijs	3.78
Vorige sluitingsprijs	1.08

Vivani Medical Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

13 mrt 2026, 19:08 UTC

Belangrijke Nieuwsgebeurtenissen

TotalEnergies Shutting Production in Qatar, Iraq Amid Fighting in Middle East

13 mrt 2026, 18:48 UTC

Winsten

Belangrijke Marktbewegers

Capricor Therapeutics Falls on Wider-Than-Expected 4Q Loss

13 mrt 2026, 17:10 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

13 mrt 2026, 17:10 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: Central Bank Decisions -2-

13 mrt 2026, 16:47 UTC

Belangrijke Nieuwsgebeurtenissen

The Week in Oil: Hormuz Crisis Pushes Brent Above $100

14 mrt 2026, 02:03 UTC

Winsten

This Copper Stock Is Worth Mining for Profits -- Barrons.com

14 mrt 2026, 01:32 UTC

Acquisities, Fusies, Overnames

Bill Ackman's Pershing Square IPO Is Back On -- Barrons.com

14 mrt 2026, 00:29 UTC

Acquisities, Fusies, Overnames

13D Filings -- Barrons.com

13 mrt 2026, 22:27 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13 mrt 2026, 22:13 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13 mrt 2026, 22:04 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13 mrt 2026, 22:00 UTC

Acquisities, Fusies, Overnames

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13 mrt 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

13 mrt 2026, 20:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Financial Services Roundup: Market Talk

13 mrt 2026, 20:02 UTC

Marktinformatie

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13 mrt 2026, 19:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13 mrt 2026, 19:35 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

13 mrt 2026, 19:00 UTC

Marktinformatie

U.S. Natural Gas Futures Settle Lower -- Market Talk

13 mrt 2026, 18:49 UTC

Belangrijke Nieuwsgebeurtenissen

The Iran War Could Upend AI. Here's How. -- Barrons.com

13 mrt 2026, 18:24 UTC

Belangrijke Nieuwsgebeurtenissen

Impact of Middle East Conflict on TotalEnergies Activities

13 mrt 2026, 18:00 UTC

Belangrijke Nieuwsgebeurtenissen

Is War Good For the Economy? -- WSJ

13 mrt 2026, 17:23 UTC

Marktinformatie

U.S. Oil Rig Count Rises by 1 to 412 -- Market Talk

13 mrt 2026, 16:46 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

European Indexes End Week Lower as Oil Takes Driving Seat -- Market Talk

13 mrt 2026, 16:38 UTC

Belangrijke Nieuwsgebeurtenissen

Higher Oil Prices Could Bring a Global Economic Shock. This Is the Number to Watch. -- Barrons.com

13 mrt 2026, 16:34 UTC

Acquisities, Fusies, Overnames

EQT Says It Received Around CHF21 Bln in Total From Galderma Share Sales

13 mrt 2026, 16:33 UTC

Acquisities, Fusies, Overnames

EQT Receives Proceeds of Around CHF1.3B From Sell-Down

13 mrt 2026, 16:32 UTC

Acquisities, Fusies, Overnames

EQT Completes Exit From Galderma

13 mrt 2026, 16:20 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Financial Services Roundup: Market Talk

13 mrt 2026, 16:20 UTC

Marktinformatie

Health Care Roundup: Market Talk

13 mrt 2026, 16:15 UTC

Belangrijke Nieuwsgebeurtenissen

Why Exxon and Energy Stocks Finally Started to Rise This Week as the Iran War Escalated -- Barrons.com

Peer Vergelijking

Prijswijziging

Vivani Medical Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

Buy

Hold

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan Vivani Medical - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Winst voor belastingen

Verkoop

Operationele winst

Over Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.